| 1 |
35354375 | Real-world safety and supportive care use of second-line 5-fluorouracil-based regimens among patients with metastatic pancreatic ductal adenocarcinoma. | 2022 Apr 22 |
1 |
| 2 |
28011495 | Granulocyte Colony-stimulating Factor Producing Anaplastic Carcinoma of the Pancreas: Case Report and Review of the Literature. | 2017 Jan |
2 |
| 3 |
22415148 | Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer. | 2012 Jun |
2 |
| 4 |
16781005 | A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer. | 2006 Aug |
2 |
| 5 |
16020968 | Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients. | 2005 |
1 |
| 6 |
15292935 | Phase I-II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer. | 2004 Sep 13 |
1 |
| 7 |
11822765 | Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. | 2001 Nov |
2 |
| 8 |
11137204 | A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy. | 2000 Dec |
1 |
| 9 |
11142689 | Phase I study of carboplatin, docetaxel and irinotecan with recombinant human granulocyte colony stimulating factor support in patients with advanced non-small cell lung cancer. | 2000 Nov |
2 |
| 10 |
10321506 | A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer. | 1999 |
1 |
| 11 |
10410150 | [Period of time patients with advanced non-small cell lung cancer could remain at home during CIC--therapy (cisplatin + ifosfamide + CPT-11)]. | 1999 May |
1 |
| 12 |
9155540 | A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer. | 1997 Mar |
3 |
| 13 |
8683231 | Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicity. | 1996 Jul |
2 |
| 14 |
8841050 | [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer]. | 1996 Sep |
2 |
| 15 |
7505810 | Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer. | 1994 Jan |
1 |
| 16 |
7521905 | Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer. | 1994 Sep |
1 |